The Supreme Court is set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
Guests:
- Hans Sauer, adjunct professor, Georgetown Law; former vice president of intellectual property, Biotechnology Innovation Organization
- Sean Tu, professor of law, University of Alabama
- Dennies Varughese, partner; Sterne, Kessler, Goldstein and Fox
- Leslie Walker, senior reporter, Tradeoffs
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
Hosted on Acast. See acast.com/privacy for more information.
